HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Proof-of-principle study to detect metabolic changes in peritoneal dialysis effluent in patients who develop encapsulating peritoneal sclerosis.

AbstractBACKGROUND:
Prolonged peritoneal dialysis (PD) therapy can result in the development of encapsulating peritoneal sclerosis (EPS), characterized by extensive sclerosis of the peritoneum with bowel adhesions often causing obstruction.
METHODS:
As a proof-of-principle study, holistic profiling of endogenous metabolites has been applied in a prospective collection of PD effluent collected in multiple UK renal centres over 6 years in order to investigate metabolic differences in PD effluent between PD therapy patients who later developed clinically defined EPS (n = 11) and controls, who were matched for PD vintage, age and gender (n = 11).
RESULTS:
'Fit-for-purpose' analytical methods employing gas chromatography-mass spectrometry (MS), direct injection MS and quality control samples were developed and validated. These methods were applied in a proof-of-principle study to define metabolic differences in PD effluent related to subsequent development of EPS. Changes in amino acids, amines and derivatives, short-chain fatty acids and derivatives and sugars were observed prior to EPS developing, and changes in the metabolomic profiles could be detected.
CONCLUSION:
There is potential for applying metabolic profiles to identify patients at risk of developing EPS although long-term prospective studies with larger patient cohorts are required.
AuthorsWarwick B Dunn, Angela Summers, Marie Brown, Royston Goodacre, Mark Lambie, Tim Johnson, Martin Wilkie, Simon Davies, Nick Topley, Paul Brenchley
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (Nephrol Dial Transplant) Vol. 27 Issue 6 Pg. 2502-10 (Jun 2012) ISSN: 1460-2385 [Electronic] England
PMID22294777 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Case-Control Studies
  • Cross-Sectional Studies
  • Follow-Up Studies
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • In Vitro Techniques
  • Kidney Failure, Chronic
  • Metabolomics
  • Peritoneal Dialysis, Continuous Ambulatory (adverse effects)
  • Peritoneum (metabolism, pathology)
  • Peritonitis (diagnosis, etiology, metabolism)
  • Prognosis
  • Prospective Studies
  • Retrospective Studies
  • Sclerosis (diagnosis, etiology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: